Related references
Note: Only part of the references are listed.Advanced topical drug delivery system for the management of vaginal candidiasis
Himmat Singh Johal et al.
DRUG DELIVERY (2016)
Advanced drug delivery approaches against periodontitis
Deeksha Joshi et al.
DRUG DELIVERY (2016)
Permeation enhancer strategies in transdermal drug delivery
Harneet Marwah et al.
DRUG DELIVERY (2016)
Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne
Tarun Garg
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2016)
Recent Advances in Polymeric Electrospun Nanofibers for Drug Delivery
Rahul Sharma et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2014)
Current Nanotechnological Strategies for an Effective Delivery of Drugs in Treatment of Periodontal Disease
Gagan Goyal et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2014)
Current Nanotechnological Strategies for Effective Delivery of Bioactive Drug Molecules in the Treatment of Tuberculosis
Mandeep Kaur et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2014)
Development and characterization of nano-fiber patch for the treatment of glaucoma
Gagandeep et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Biomaterial-based scaffolds - current status and future directions
Tarun Garg et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Stimuli-Sensitive Hydrogels: An Excellent Carrier for Drug and Cell Delivery
Tarun Garg et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2013)
Scaffold: A Novel Carrier for Cell and Drug Delivery
Tarun Garg et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an In vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B
Dongmei Lu et al.
PHARMACEUTICAL RESEARCH (2007)
Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model
L. Garcia-Contreras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis
M. S. El-Ridy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis
S Gelperina et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis
A Zahoor et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Oral solid lipid nanoparticle-based antitubercular chemotherapy
R Pandey et al.
TUBERCULOSIS (2005)
Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis
R Pandey et al.
TUBERCULOSIS (2005)
Antitubercular inhaled therapy: opportunities, progress and challenges
R Pandey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery
F Gabor et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages
SP Vyas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis
A Sharma et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects
Qurrat-ul-Ain et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis
R Pandey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Screening in an infectious disease model
S Suarez et al.
PHARMACEUTICAL RESEARCH (2001)
Share Paper
